Utilizing a passionate and talented team, VoxCell is creating an extraordinary line of Truly Biomimetic solutions for the drug development industry and the field of Oncology research, vascularized cancer tissue models. Our 3D Bioprinter uses a state of the art laser with a process that crosslinks bioink with extreme precision, producing incredible high resolution 3D printed tissues. Combined with our proprietary software, we are able to print tissues with vasculature for more meaningful in vitro testing. This process occurs only at the focal point of the laser (the voxel, hence VoxCell), allowing for printing anywhere in the polymer, including within structures, unlike traditional extrusion based 3D bioprinters.
Our tissue models will increase confidence in new drug candidates, decrease the failure rate (currently more than 95% of drugs fail), and increase the time for new therapies to get to market. Currently, the successful translation between pre-clinical trial data and clinical trial results is less than 8%.
Testing on truly biomimetic tissues will provide better data to identify and eliminate unsuccessful drug candidates sooner, increasing the throughput and reducing the volume and cost of animal and human testing, ultimately getting life saving therapies to market and in the hands of people who need them sooner.